` ILA (Island Pharmaceuticals Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

ILA
vs
S
S&P/ASX 300

Over the past 12 months, ILA has significantly outperformed S&P/ASX 300, delivering a return of +156% compared to the S&P/ASX 300's +7% growth.

Stocks Performance
ILA vs S&P/ASX 300

Loading
ILA
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ILA vs S&P/ASX 300

Performance Gap Between ILA and AXKO
HIDDEN
Show

Performance By Year
ILA vs S&P/ASX 300

Loading
ILA
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Island Pharmaceuticals Ltd vs Peers

S&P/ASX 300
ILA
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Island Pharmaceuticals Ltd
Glance View

Market Cap
123.8m AUD
Industry
Pharmaceuticals

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-04-13. The firm focuses on developing preventative or therapeutic drugs for viral infections. Its lead product candidate ISLA-101, is a drug developed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. Its ISLA-101 is an antiviral oral drug to treat mosquito-borne viruses and is in Phase II of the clinical program.

ILA Intrinsic Value
HIDDEN
Show
Back to Top